Skip to main content
. 2013 Dec 20;54(1):26–30. doi: 10.3164/jcbn.13-87

Fig. 2.

Fig. 2

Tissue immunostained for SLC46A1 protein. While the malignant tumor area (upper area) was stained with antibody against SLC46A1, the normal area (bottom area) was not stained with this antibody (×200).